A Prospective Interventional Study Assessing the Clinical and Operational Effectiveness of Transitioning From Mircera to Daprodustat for the Treatment of Anemia in End Stage Kidney Disease
Clinical trial NCT05951192 · COMPLETED
Trial details
- NCT number
- NCT05951192
- Sponsor
- USRC Kidney Research
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-01
- Primary completion
- 2024-02-14
- Enrollment
- 161
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.